Packaging Size | 30 gm |
Brand | RUTINIB |
Type Of Skin Ointment | Organic Chemicals |
Product Type | CREAM |
Time Used | Day |
Manufacturer | DRUG INT |
Usage | To treat mild to moderate atopic dermatitis (eczema) i |
Also gives | PCD Pharma Franchise |
The cream form of ruxolitinib is used to treat a skin condition called eczema (atopic dermatitis) in people who should not use or have not responded to other eczema medications. Eczema is an allergic-type condition that causes red, irritated, and itchy skin.
About This Medicine: The US Food and Drug Administration (FDA) approved ruxolitinib (Opzelura) cream 1.5% for the treatment of nonsegmental vitiligo in adults and pediatric patients 12 years and older, making it the first FDA-approved treatment for repigmentation of the skin in patients with the condition.
SKU-NIFAU31GSA1P
Packaging Size | 30 gm |
Brand | RUTINIB |
Type Of Skin Ointment | Organic Chemicals |
Product Type | CREAM |
Time Used | Day |
Manufacturer | DRUG INT |
Usage | To treat mild to moderate atopic dermatitis (eczema) i |
Also gives | PCD Pharma Franchise |
The cream form of ruxolitinib is used to treat a skin condition called eczema (atopic dermatitis) in people who should not use or have not responded to other eczema medications. Eczema is an allergic-type condition that causes red, irritated, and itchy skin.
About This Medicine: The US Food and Drug Administration (FDA) approved ruxolitinib (Opzelura) cream 1.5% for the treatment of nonsegmental vitiligo in adults and pediatric patients 12 years and older, making it the first FDA-approved treatment for repigmentation of the skin in patients with the condition.